BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34211435)

  • 21. A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome.
    De Frène V; Vansteelandt S; T'Sjoen G; Gerris J; Somers S; Vercruysse L; De Sutter P
    Hum Reprod; 2014 Oct; 29(10):2333-8. PubMed ID: 24963163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry.
    Sun Z; Chang HM; Wang A; Song J; Zhang X; Guo J; Leung PCK; Lian F
    Reprod Biol Endocrinol; 2019 Jun; 17(1):45. PubMed ID: 31186025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing pregnancy, childbirth, and neonatal outcomes in women with different phenotypes of polycystic ovary syndrome and healthy women: a prospective cohort study.
    Foroozanfard F; Asemi Z; Bazarganipour F; Taghavi SA; Allan H; Aramesh S
    Gynecol Endocrinol; 2020 Jan; 36(1):61-65. PubMed ID: 31264483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of Novel Lipid Profiles in PCOS: Do Insulin and Androgen Oppositely Regulate Bioactive Lipid Production?
    Li S; Chu Q; Ma J; Sun Y; Tao T; Huang R; Liao Y; Yue J; Zheng J; Wang L; Xue X; Zhu M; Kang X; Yin H; Liu W
    J Clin Endocrinol Metab; 2017 Mar; 102(3):810-821. PubMed ID: 27886515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome.
    Kuang H; Jin S; Hansen KR; Diamond MP; Coutifaris C; Casson P; Christman G; Alvero R; Huang H; Bates GW; Usadi R; Lucidi S; Baker V; Santoro N; Eisenberg E; Legro RS; Zhang H;
    Hum Reprod; 2015 Sep; 30(9):2222-33. PubMed ID: 26202922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.
    Mostinckx L; Segers I; Belva F; Buyl R; Santos-Ribeiro S; Blockeel C; Smitz J; Anckaert E; Tournaye H; De Vos M
    Hum Reprod; 2019 Aug; 34(8):1595-1607. PubMed ID: 31347678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary steroid profiling in women hints at a diagnostic signature of the polycystic ovary syndrome: A pilot study considering neglected steroid metabolites.
    Dhayat NA; Marti N; Kollmann Z; Troendle A; Bally L; Escher G; Grössl M; Ackermann D; Ponte B; Pruijm M; Müller M; Vogt B; Birkhäuser MH; Bochud M; Flück CE;
    PLoS One; 2018; 13(10):e0203903. PubMed ID: 30308019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follistatin and activins in polycystic ovary syndrome: relationship to metabolic and hormonal markers.
    Teede H; Ng S; Hedger M; Moran L
    Metabolism; 2013 Oct; 62(10):1394-400. PubMed ID: 23768911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyper response to ovarian stimulation affects the follicular fluid metabolomic profile of women undergoing IVF similarly to polycystic ovary syndrome.
    Cordeiro FB; Cataldi TR; de Souza BZ; Rochetti RC; Fraietta R; Labate CA; Lo Turco EG
    Metabolomics; 2018 Mar; 14(4):51. PubMed ID: 30830356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolomics in polycystic ovary syndrome.
    Murri M; Insenser M; Escobar-Morreale HF
    Clin Chim Acta; 2014 Feb; 429():181-8. PubMed ID: 24368231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
    Glueck CJ; Sieve L; Zhu B; Wang P
    Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of kisspeptin in polycystic ovarian syndrome: A metabolomics study.
    Zhao T; Xiao X; Li L; Tao X; He W; Zhang Q; Wu X; Yuan T
    Clin Endocrinol (Oxf); 2023 Sep; 99(3):315-325. PubMed ID: 36843187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of 25-hydroxyvitamin D and metabolic parameters between women with and without polycystic ovarian syndrome.
    Ng BK; Lee CL; Lim PS; Othman H; Ismail NAM
    Horm Mol Biol Clin Investig; 2017 Jun; 31(3):. PubMed ID: 28586302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome.
    Cree-Green M; Carreau AM; Rahat H; Garcia-Reyes Y; Bergman BC; Pyle L; Nadeau KJ
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E707-E718. PubMed ID: 30753112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis.
    Zhao Y; Fu L; Li R; Wang LN; Yang Y; Liu NN; Zhang CM; Wang Y; Liu P; Tu BB; Zhang X; Qiao J
    BMC Med; 2012 Nov; 10():153. PubMed ID: 23198915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of sleep-disordered breathing on metabolic dysfunctions in patients with polycystic ovary syndrome.
    Chatterjee B; Suri J; Suri JC; Mittal P; Adhikari T
    Sleep Med; 2014 Dec; 15(12):1547-53. PubMed ID: 25311833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic heterogeneity of follicular amino acids in polycystic ovary syndrome is affected by obesity and related to pregnancy outcome.
    Zhang CM; Zhao Y; Li R; Yu Y; Yan LY; Li L; Liu NN; Liu P; Qiao J
    BMC Pregnancy Childbirth; 2014 Jan; 14():11. PubMed ID: 24410809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS).
    Daghestani MH; Daghestani M; Daghistani M; El-Mazny A; Bjørklund G; Chirumbolo S; Al Saggaf SH; Warsy A
    Lipids Health Dis; 2018 Aug; 17(1):195. PubMed ID: 30131073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS.
    Wang W; Wang S; Tan S; Wen M; Qian Y; Zeng X; Guo Y; Yu C
    Clin Chim Acta; 2015 Aug; 448():39-47. PubMed ID: 26093338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMR Metabolomics Show Evidence for Mitochondrial Oxidative Stress in a Mouse Model of Polycystic Ovary Syndrome.
    Selen ES; Bolandnazar Z; Tonelli M; Bütz DE; Haviland JA; Porter WP; Assadi-Porter FM
    J Proteome Res; 2015 Aug; 14(8):3284-91. PubMed ID: 26076986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.